ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT)
Clinical trials for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT) explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT) trials appear
Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a feeding tube after transplant prevent deadly gut complications?
Disease control Not yet recruitingThis study tests whether starting tube feeding right after a stem cell transplant can lower the risk of severe gut graft-versus-host disease (GVHD), a serious complication. About 112 adults with blood cancers or disorders will be randomly assigned to either standard nutrition car…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT)
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Stem cell recovery under the microscope: new study tracks Patients' strength and mobility
Knowledge-focused Not yet recruitingThis study follows 140 adults receiving a donor stem cell transplant to see how their physical function changes over time. Researchers will measure strength, balance, walking speed, and daily activity levels. No new treatment is given—this is an observation-only study to better u…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT)
Sponsor: University of Dublin, Trinity College • Aim: Knowledge-focused
Last updated May 17, 2026 11:54 UTC